Literature DB >> 8221158

GABAergic neurons of the rat dorsal hippocampus express muscarinic acetylcholine receptors.

E A Van der Zee1, P G Luiten.   

Abstract

The expression of muscarinic acetylcholine receptors (mAChRs) in glutamic acid decarboxylase (GAD)-positive cells in the different strata of CA1, CA3, and the dentate gyrus (DG) of the dorsal hippocampus is examined by way of quantitative immunofluorescent double labeling employing M35, the monoclonal antibody raised against purified mAChR protein. Of all GAD-positive neurons, 97.5% express mAChRs. Conversely, 92.9% of the muscarinic cholinoceptive nonpyramidal neurons express GAD. These results indicate that the vast majority of the gamma-aminobutyric acid (GABA)ergic neurons express mAChRs. In addition to GAD, parvalbumin (PARV) and somatostatin (SOM) are two neurochemical substances notably expressed in GABAergic neurons. In order to examine whether the entire muscarinic cholinoceptive nonpyramidal cell group can be characterized by these three GABAergic markers, a cocktail of GAD, PARV, and SOM was used in a fluorescent double-labeling experiment with M35. These results show that 97.2% of all muscarinic cholinoceptive nonpyramidal neurons can be neurochemically characterized by the content of GAD, PARV, and SOM. In conclusion, nearly all GABAergic cells express mAChRs and, conversely, virtually the entire muscarinic cholinoceptive nonpyramidal cell group belongs to the GABAergic cell population. This study, therefore, provides anatomical evidence for an extensive neuronal connectivity of the hippocampal muscarinic cholinoceptive nonpyramidal system and the inhibitory GABAergic circuitry.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8221158     DOI: 10.1016/0361-9230(93)90161-4

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  6 in total

Review 1.  The cholinergic system and neostriatal memory functions.

Authors:  Robbert Havekes; Ted Abel; Eddy A Van der Zee
Journal:  Behav Brain Res       Date:  2010-12-01       Impact factor: 3.332

2.  Potential frameworks to support evaluation of mechanistic data for developmental neurotoxicity outcomes: A symposium report.

Authors:  Laura M Carlson; Frances A Champagne; Deborah A Cory-Slechta; Laura Dishaw; Elaine Faustman; William Mundy; Deborah Segal; Christina Sobin; Carol Starkey; Michele Taylor; Susan L Makris; Andrew Kraft
Journal:  Neurotoxicol Teratol       Date:  2020-02-14       Impact factor: 3.763

3.  Modulation of cortical acetylcholine release by serotonin: the role of substance P interneurons.

Authors:  T J Feuerstein; O Gleichauf; G B Landwehrmeyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

4.  Vanillin improves scopolamine‑induced memory impairment through restoration of ID1 expression in the mouse hippocampus.

Authors:  Jae-Chul Lee; In Hye Kim; Jeong Hwi Cho; Tae-Kyeong Lee; Joon Ha Park; Ji Hyeon Ahn; Bich Na Shin; Bing Chun Yan; Jong-Dai Kim; Yong Hwan Jeon; Young Joo Lee; Moo-Ho Won; Il Jun Kang
Journal:  Mol Med Rep       Date:  2018-01-09       Impact factor: 2.952

5.  Effects of acetylcholine on neuronal properties in entorhinal cortex.

Authors:  James G Heys; Nathan W Schultheiss; Christopher F Shay; Yusuke Tsuno; Michael E Hasselmo
Journal:  Front Behav Neurosci       Date:  2012-07-24       Impact factor: 3.558

6.  Effects of long‑term scopolamine treatment on cognitive deficits and calcium binding proteins immunoreactivities in the mouse hippocampus.

Authors:  Ji Hyeon Ahn; Bai Hui Chen; Bing Chun Yan; Joon Ha Park; Il Jun Kang; Tae-Kyeong Lee; Jeong Hwi Cho; Bich-Na Shin; Jae-Chul Lee; Yong Hwan Jeon; Seongkweon Hong; Young Joo Lee; Soo Young Choi; Moo-Ho Won
Journal:  Mol Med Rep       Date:  2017-10-27       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.